checkAd

     101  0 Kommentare The Law Offices of Frank R. Cruz Announces Investigation of Veradigm Inc. (MDRX) on Behalf of Investors

    The Law Offices of Frank R. Cruz announces an investigation of Veradigm Inc. (“Veradigm” or the “Company”) (NASDAQ: MDRX) concerning whether the board of directors breached its fiduciary duties to Veradigm shareholders.

    If you are a shareholder who suffered a loss, click here to participate.

    On February 28, 2023, Veradigm disclosed that it “detected certain internal control failures related to revenue recognition that have occurred over the prior six quarters,” resulting in a $20 million overstatement of revenue over those periods. Then, on March 22, 2023, Veradigm disclosed that the cumulative impact of its corrections “will increase to approximately $40 million” and that “the impact for 2021 will require a restatement of the Company’s financial statements as of and for the year ended December 31, 2021.”

    Follow us for updates on Twitter: twitter.com/FRC_LAW.

    If you still hold Veradigm shares purchased before December 2020, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Frank R. Cruz, of The Law Offices of Frank R. Cruz, 2121 Avenue of the Stars, Suite 800, Century City, California 90067 at 310-914-5007, by email to info@frankcruzlaw.com, or visit our website at www.frankcruzlaw.com. If you inquire by email please include your mailing address, telephone number, and number of shares purchased.

    This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.




    Business Wire (engl.)
    0 Follower
    Autor folgen
    The Law Offices of Frank R. Cruz Announces Investigation of Veradigm Inc. (MDRX) on Behalf of Investors The Law Offices of Frank R. Cruz announces an investigation of Veradigm Inc. (“Veradigm” or the “Company”) (NASDAQ: MDRX) concerning whether the board of directors breached its fiduciary duties to Veradigm shareholders. If you are a shareholder who …